1. Home
  2. CTXR vs MCHX Comparison

CTXR vs MCHX Comparison

Compare CTXR & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • MCHX
  • Stock Information
  • Founded
  • CTXR 2007
  • MCHX 2003
  • Country
  • CTXR United States
  • MCHX United States
  • Employees
  • CTXR N/A
  • MCHX N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • MCHX Business Services
  • Sector
  • CTXR Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • CTXR Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • CTXR 84.9M
  • MCHX 79.9M
  • IPO Year
  • CTXR N/A
  • MCHX 2004
  • Fundamental
  • Price
  • CTXR $2.65
  • MCHX $2.10
  • Analyst Decision
  • CTXR Buy
  • MCHX
  • Analyst Count
  • CTXR 2
  • MCHX 0
  • Target Price
  • CTXR $100.00
  • MCHX N/A
  • AVG Volume (30 Days)
  • CTXR 561.0K
  • MCHX 107.8K
  • Earning Date
  • CTXR 02-12-2025
  • MCHX 10-31-2024
  • Dividend Yield
  • CTXR N/A
  • MCHX N/A
  • EPS Growth
  • CTXR N/A
  • MCHX N/A
  • EPS
  • CTXR N/A
  • MCHX N/A
  • Revenue
  • CTXR N/A
  • MCHX $48,594,000.00
  • Revenue This Year
  • CTXR N/A
  • MCHX N/A
  • Revenue Next Year
  • CTXR N/A
  • MCHX $4.63
  • P/E Ratio
  • CTXR N/A
  • MCHX N/A
  • Revenue Growth
  • CTXR N/A
  • MCHX N/A
  • 52 Week Low
  • CTXR $2.44
  • MCHX $1.11
  • 52 Week High
  • CTXR $26.75
  • MCHX $2.40
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 30.59
  • MCHX 63.40
  • Support Level
  • CTXR $2.44
  • MCHX $1.98
  • Resistance Level
  • CTXR $2.85
  • MCHX $2.40
  • Average True Range (ATR)
  • CTXR 0.34
  • MCHX 0.15
  • MACD
  • CTXR 0.15
  • MCHX 0.02
  • Stochastic Oscillator
  • CTXR 24.99
  • MCHX 59.23

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: